On September 5, a delegation from LifeShare Network in the United States, including Professor Jeffrey P. Orlowski, Chief Executive Officer (CEO), Ronald Andrew Squires, Chief Medical Officer (CMO), and Professor Shi-Feng Li, Organ Recovery Specialist (ORS), visited the First Affiliated Hospital (FAH) of Xi’an Jiaotong University (XJTU) to exchange views on organ donation. Professor Xue Wujun, Chairman of the Branch of Organ Transplantation of Chinese Medical Association, Professor Huang Yaxun from Second Xiangya Hospital of Central South University, Ding Chenguang, Director of the Organ Procurement Organization (OPO), the FAH of XJTU, Xiang Heli, Deputy Director of the Department of Kidney Transplantation, as well as experts in liver, heart, and lung transplantation and the entire OPO team participated in the exchanges.
In his address, Professor Xue Wujun emphasized that organ donation and transplantation is a cause of life and hope, and international cooperation is of great importance. He noted that the United States has accumulated rich experience in organ donation through years of development. This visit offers us a valuable opportunity for learning and provides meaningful insights for improving China’s organ donation and transplantation system. He expressed the expectation that closer cooperative mechanisms will be established in the future.

Professor Jeffrey P. Orlowski commended the progress China has made in the field of organ transplantation and shared the management experience of LifeShare Network OPO. He expressed his hope that through the exchanges, he could also learn from China’s practices and apply China’s advanced experience to organ donation work in the United States.

Professor Ding Chenguang and Professor Shi-Feng Li shared their experience respectively on the discipline-based development of the XJTU OPO and the mechanical perfusion of marginal donor organs.
Subsequently, experts engaged in in-depth exchanges and discussions on topics such as donor evaluation, preservation of marginal organs, normothermic perfusion, and donor contraindications, mutually sharing their clinical practice experience.

The exchanges have opened a new chapter and forged a stronger consensus for the development of organ donation and transplantation in the FAH. Building on a solid foundation of domestic progress, the Department will continue to deepen exchanges and mutual learning with leading international OPOs, driving the discipline-based development of OPO to new heights and achieving tangible results.


